BFC Planning’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.68K Hold
202
– – ﹤0.01% 2809
2026
Q2
$4.56K Buy
202
+53
+36% +$1.33K ﹤0.01% 2711
2026
Q1
$3.73K Buy
149
+33
+28% +$930 ﹤0.01% 2417
2025
Q4
$3.65K Hold
116
– – ﹤0.01% 2457
2025
Q3
$4.14K Hold
116
– – ﹤0.01% 2260
2025
Q2
$6.68K Hold
116
– – ﹤0.01% 1958
2025
Q1
$6.76K Hold
116
– – ﹤0.01% 1913
2024
Q4
$9.34K Sell
116
-37
-24% -$3.16K ﹤0.01% 1791
2024
Q3
$12.3K Buy
+153
New +$10.9K ﹤0.01% 1652

Other funds holding PRCT

BFC Planning's PRCT Position: Q3 2026 in Review

BFC Planning held its Procept Biorobotics (PRCT) position steady in Q3 2026 at 202 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

BFC Planning first reported a position in PRCT in Q3 2024 and has held it in 9 quarters since. The position peaked at $12.3K in Q3 2024. 171 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • BFC Planning held 202 shares of Procept Biorobotics worth $3.68K as of Q3 2026.
  • BFC Planning left its Procept Biorobotics share count unchanged in Q3 2026.
  • Procept Biorobotics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2809 holding.
  • BFC Planning first reported a position in Procept Biorobotics in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Procept Biorobotics position peaked at $12.3K in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.